| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/01/2010 | US20100168199 Kinase Inhibitors |
| 07/01/2010 | US20100168196 N-Substituted (Benzoimidazol-2-yl)phenylamines, Processes for Their Preparation, Their Use as a Medicament or Diagnostic Aid, and a Medicament Comprising Them |
| 07/01/2010 | US20100168195 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists |
| 07/01/2010 | US20100168193 Therapeutic use of imidazole-5-carboxylic acid derivatives |
| 07/01/2010 | US20100168192 Benzisoxazole derivatives as potassium channel modulators for the treatment of e.g. respiratory diseases, epilepsy and convulsions |
| 07/01/2010 | US20100168188 Estrogen Receptor Modulators |
| 07/01/2010 | US20100168187 Therapeutic combination |
| 07/01/2010 | US20100168186 Pre-Mixed, Ready-To-Use Pharmaceutical Compositions |
| 07/01/2010 | US20100168169 Substituted 1,3-dioxanes useful as ppar modulators |
| 07/01/2010 | US20100168159 Hetero compound |
| 07/01/2010 | US20100168156 Novel Benzoxathiine Derivative |
| 07/01/2010 | US20100168144 Inhibitors of protein kinases |
| 07/01/2010 | US20100168139 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/01/2010 | US20100168137 Combination for use in the treatment of inflammatory disorders |
| 07/01/2010 | US20100168115 Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect |
| 07/01/2010 | US20100168113 Pharmaceutical Compounds |
| 07/01/2010 | US20100168110 Novel Compounds |
| 07/01/2010 | US20100168107 Imidazole compounds for the treatment of neurodegenerative disorders |
| 07/01/2010 | US20100168103 Diaryl piperidine compounds as calcium channel blockers |
| 07/01/2010 | US20100168102 Amide Derivatives as Kinase Inhibitors |
| 07/01/2010 | US20100168078 S1p receptor modulators for treating multiple sclerosis |
| 07/01/2010 | US20100168077 Novel Pyridine Derivatives, Processes for Preparing Them, Pharmaceutical Compositions Thereof |
| 07/01/2010 | US20100168075 Novel 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions |
| 07/01/2010 | US20100168073 Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| 07/01/2010 | US20100168070 Compounds for the treatment of alzheimer's disease |
| 07/01/2010 | US20100168056 Dietary fiber formulation and method of administration |
| 07/01/2010 | US20100168051 Altered Mitochondrial Activity in Diseases Resulting From Oxidative Stress |
| 07/01/2010 | US20100168039 Novel 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions |
| 07/01/2010 | US20100168036 Growth factor |
| 07/01/2010 | US20100168032 Smart Pro-Drugs of Serine Protease Inhibitors |
| 07/01/2010 | US20100168030 Methods and compositions for treatment of organophosphate-caused pathology |
| 07/01/2010 | US20100168025 Stroke-generated angiogenesis enhancers and uses thereof |
| 07/01/2010 | US20100168021 Urocortin proteins and uses thereof |
| 07/01/2010 | US20100168009 PHa1B TOXIN, cDNA of Pha1B TOXIN GENE, PHARMACEUTICAL COMPOSITION CONTAINING PHa1B TOXIN, PROCESS AND PRODUCT |
| 07/01/2010 | US20100167986 Cholesteryl Ester Transfer Protein Inhibitors |
| 07/01/2010 | US20100166878 Composition comprising bee venom for the treatment of atherosclerosis |
| 07/01/2010 | US20100166869 Methods and compositions for treating pulmonary hypertension |
| 07/01/2010 | US20100166862 Local Complement Inhibition for Treatment of Complement-Mediated Disorders |
| 07/01/2010 | US20100166857 Pharmaceutical dosage forms and methods of manufacturing same |
| 07/01/2010 | US20100166839 Non peptidic renin inhibitors nitroderivatives |
| 07/01/2010 | US20100166837 1,(3,)5-substituted imidazoles, their use in the treatment of hypertension and methods for their preparation |
| 07/01/2010 | US20100166827 Periostin induces proliferation of cardiomyocytes and promotes cardiac regeneration |
| 07/01/2010 | US20100166824 Extracellular matrix compositions |
| 07/01/2010 | US20100166819 Transforming Growth Factor Modulators |
| 07/01/2010 | US20100166792 Antigenic Polypeptides |
| 07/01/2010 | US20100166757 Antibodies against monocyte chemotactic proteins |
| 07/01/2010 | US20100166733 Mcp-1 splice variants and methods of using same |
| 07/01/2010 | US20100166728 Novel Highly Functional Enzyme Having Modified Substrate-Specificity |
| 07/01/2010 | US20100166717 Method of treating ischemic disorders |
| 07/01/2010 | US20100166714 Cardiovascular stem cells, methods for stem cell isolation, and uses thereof |
| 07/01/2010 | US20100166667 Magnetic resonance imaging |
| 07/01/2010 | US20100166654 Single-Drug Multi-Ligand Conjugates for Targeted Drug Delivery |
| 07/01/2010 | DE102008062426A1 Medicament, useful for congelation prevention and congelation treatment, comprises Hypericium perforatum, Betula pendula, Polygonum aviculare, Origanum vulgare, Glycyrrhiza glabra, Rosa majalis, Calendula officinalis |
| 07/01/2010 | CA2748289A1 Preparation method of dihydroindene amide compounds,their pharmaceutical compositions containing compounds thereof and use as protein kinase inhibitor |
| 07/01/2010 | CA2748124A1 Ppar agonist compositions and methods of use |
| 07/01/2010 | CA2747996A1 Compounds and methods for enhancing erythropoiesis |
| 07/01/2010 | CA2747809A1 Bicyclic heterocycle derivatives and methods of use thereof |
| 06/30/2010 | EP2202295A1 Method for efficient production of monocyte-derived multipotent cell (momc) |
| 06/30/2010 | EP2202241A2 Therapeutic compounds and methods for modulating V3, a versican isoform |
| 06/30/2010 | EP2202240A1 Compound |
| 06/30/2010 | EP2202231A1 2,3-dihydroiminoisoindole derivative |
| 06/30/2010 | EP2202228A1 Amide compounds and use of the same |
| 06/30/2010 | EP2202225A1 New method for synthesising ivabradine and its added salts with a pharmaceutically acceptable acid. |
| 06/30/2010 | EP2201945A2 Substituted 2-Aminoacetamides and the Use Thereof |
| 06/30/2010 | EP2201944A2 Substituted 2-Aminoacetamides and the Use Thereof |
| 06/30/2010 | EP2201897A2 Tumor targeted photodiagnostic-phototherapeutic agents |
| 06/30/2010 | EP2201384A2 Future cardiac event biomarkers |
| 06/30/2010 | EP2201011A2 Novel compounds having indazole frameworks, methods for preparing the same and pharmaceutical composition comprising the same |
| 06/30/2010 | EP2201007A1 Cannabinoid receptor ligands |
| 06/30/2010 | EP2200994A1 Condensed compounds with activity at estrogen receptors |
| 06/30/2010 | EP2200977A2 F1f0-atpase inhibitors and related methods |
| 06/30/2010 | EP2200975A1 Dual-acting antihypertensive agents |
| 06/30/2010 | EP2200967A2 New no-donor aspirin derivatives |
| 06/30/2010 | EP2200652A2 Microbubbles and methods for oxygen delivery |
| 06/30/2010 | EP2200630A1 Treatment of cardiovascular disorders using the cell differentiation signaling protein nell1 |
| 06/30/2010 | EP2200628A2 Disease treatment via antimicrobial peptides or their inhibitors |
| 06/30/2010 | EP2200622A1 Adherent cells from adipose or placenta tissues and use thereof in therapy |
| 06/30/2010 | EP2200615A1 A3 adenosine receptor antagonists |
| 06/30/2010 | EP2200614A1 Treatment of vasomotor symptoms |
| 06/30/2010 | EP2200591A2 Controlled release pharmaceutical dosage forms of trimetazidine |
| 06/30/2010 | EP2200427A1 Use of neuregulin for organ preservation |
| 06/30/2010 | EP1891008B1 Oxindoles as kinase inhibitors |
| 06/30/2010 | EP1735270B1 Diamino alcohols and their use as renin inhibitors |
| 06/30/2010 | EP1575589B1 Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives |
| 06/30/2010 | EP1558572B1 Novel compounds and their use as prar-modulators |
| 06/30/2010 | EP1531180B1 Method of diagnosing risk of myocardial infarction |
| 06/30/2010 | EP1476435B1 Novel pyridin- and pyrimidin-derivatives |
| 06/30/2010 | EP1465616B1 Treatment of statin side effects using uridine derivatives |
| 06/30/2010 | EP1368323B1 Pyrimidine matrix metalloproteinase inhibitors |
| 06/30/2010 | EP1284727B1 Intracorporeal medicaments for photodynamic treatment of disease |
| 06/30/2010 | CN1895259B Preparation of injection for treating cardiovascular disease |
| 06/30/2010 | CN1533276B Use of thiazole derivatives for preparing medicine for protecting mitochondria |
| 06/30/2010 | CN101765593A 2-iminoisothiazole derivatives as cannabinoid receptor ligands |
| 06/30/2010 | CN101765425A The use of benzamide derivatives for the treatment of cns disorders |
| 06/30/2010 | CN101760446A Method for preparing monocyte type stem cell and application |
| 06/30/2010 | CN101760337A Candle for accelerating blood circulation |
| 06/30/2010 | CN101759778A Active spider polypeptide, preparation method and application thereof |
| 06/30/2010 | CN101759775A Leech active small peptide and preparation method and application thereof |
| 06/30/2010 | CN101759752A Ginsenoside Rg 1 containing ginsenoside Rg 2 impurity |
| 06/30/2010 | CN101759751A Ginsenoside Rg 1 containing ginsenoside Re impurity |